348 related articles for article (PubMed ID: 29549634)
21. The use of antibodies in the treatment of infectious diseases.
Chan CE; Chan AH; Hanson BJ; Ooi EE
Singapore Med J; 2009 Jul; 50(7):663-72; quiz 673. PubMed ID: 19644620
[TBL] [Abstract][Full Text] [Related]
22. Construction of Rabbit Immune Antibody Libraries.
Nguyen TTH; Lee JS; Shim H
Methods Mol Biol; 2023; 2702():93-106. PubMed ID: 37679617
[TBL] [Abstract][Full Text] [Related]
23. [Next-Generation Techniques for Discovering Human Monoclonal Antibodies].
Lushova AA; Biazrova MG; Prilipov AG; Sadykova GK; Kopylov TA; Filatov AV
Mol Biol (Mosk); 2017; 51(6):899-906. PubMed ID: 29271955
[TBL] [Abstract][Full Text] [Related]
24. Recombinant Antibody Selections by Combining Phage and Yeast Display.
Ferrara F; Soluri MF; Sblattero D
Methods Mol Biol; 2019; 1904():339-352. PubMed ID: 30539479
[TBL] [Abstract][Full Text] [Related]
25. [Recombinant antibodies against bioweapons].
Thullier P; Pelat T; Vidal D
Med Sci (Paris); 2009 Dec; 25(12):1145-8. PubMed ID: 20035695
[TBL] [Abstract][Full Text] [Related]
26. Broad specificity of immune helminth scFv library to identify monoclonal antibodies targeting Strongyloides.
Rahumatullah A; Balachandra D; Noordin R; Baharudeen Z; Lim YY; Choong YS; Lim TS
Sci Rep; 2021 Jan; 11(1):2502. PubMed ID: 33510342
[TBL] [Abstract][Full Text] [Related]
27. Design and construction of a naïve mouse antibody phage display library.
Sommavilla R; Lovato V; Villa A; Sgier D; Neri D
J Immunol Methods; 2010 Feb; 353(1-2):31-43. PubMed ID: 20093119
[TBL] [Abstract][Full Text] [Related]
28. Construction of Macaque Immune-Libraries.
Avril A; Miethe S; Hust M; Pelat T
Methods Mol Biol; 2018; 1701():83-112. PubMed ID: 29116501
[TBL] [Abstract][Full Text] [Related]
29. Isolation of monoclonal antibody fragments from phage display libraries.
Arbabi-Ghahroudi M; Tanha J; MacKenzie R
Methods Mol Biol; 2009; 502():341-64. PubMed ID: 19082566
[TBL] [Abstract][Full Text] [Related]
30. Antibodies in infectious diseases: polyclonals, monoclonals and niche biotechnology.
Berry JD; Gaudet RG
N Biotechnol; 2011 Sep; 28(5):489-501. PubMed ID: 21473942
[TBL] [Abstract][Full Text] [Related]
31. Phage display for the production of human monoclonal antibodies against human pathogens.
Mancini N; Carletti S; Perotti M; Canducci F; Mammarella M; Sampaolo M; Burioni R
New Microbiol; 2004 Oct; 27(4):315-28. PubMed ID: 15646045
[TBL] [Abstract][Full Text] [Related]
32. Construction of Rabbit Immune Antibody Libraries.
Nguyen TTH; Lee JS; Shim H
Methods Mol Biol; 2018; 1701():133-146. PubMed ID: 29116503
[TBL] [Abstract][Full Text] [Related]
33. Antibody-based therapies for emerging infectious diseases.
Casadevall A
Emerg Infect Dis; 1996; 2(3):200-8. PubMed ID: 8903230
[TBL] [Abstract][Full Text] [Related]
34. Developing recombinant antibodies by phage display technology to neutralize viral infectious diseases.
Mustafa MI; Mohammed A
SLAS Discov; 2024 Apr; 29(3):100140. PubMed ID: 38182043
[TBL] [Abstract][Full Text] [Related]
35. [Monoclonal antibodies for treating infectious diseases].
Klinguer-Hamour C; Caussanel V; Beck A
Med Sci (Paris); 2009 Dec; 25(12):1116-20. PubMed ID: 20035689
[TBL] [Abstract][Full Text] [Related]
36. Phage Display Derived Monoclonal Antibodies: From Bench to Bedside.
Alfaleh MA; Alsaab HO; Mahmoud AB; Alkayyal AA; Jones ML; Mahler SM; Hashem AM
Front Immunol; 2020; 11():1986. PubMed ID: 32983137
[TBL] [Abstract][Full Text] [Related]
37. Rabbit immune repertoires as sources for therapeutic monoclonal antibodies: the impact of kappa allotype-correlated variation in cysteine content on antibody libraries selected by phage display.
Popkov M; Mage RG; Alexander CB; Thundivalappil S; Barbas CF; Rader C
J Mol Biol; 2003 Jan; 325(2):325-35. PubMed ID: 12488098
[TBL] [Abstract][Full Text] [Related]
38. Semiautomated panning of naive camelidae libraries and selection of single-domain antibodies against peptide antigens.
Kumaran J; Mackenzie CR; Arbabi-Ghahroudi M
Methods Mol Biol; 2012; 911():105-24. PubMed ID: 22886248
[TBL] [Abstract][Full Text] [Related]
39. A combination of in vitro techniques for efficient discovery of functional monoclonal antibodies against human CXC chemokine receptor-2 (CXCR2).
Boshuizen RS; Marsden C; Turkstra J; Rossant CJ; Slootstra J; Copley C; Schwamborn K
MAbs; 2014; 6(6):1415-24. PubMed ID: 25484047
[TBL] [Abstract][Full Text] [Related]
40. A platform-agnostic, function first-based antibody discovery strategy using plasmid-free mammalian expression of antibodies.
Zhang R; Prabakaran P; Yu X; Mackness BC; Boudanova E; Hopke J; Sancho J; Saleh J; Cho H; Zhang N; Simonds-Mannes H; Stimple SD; Hoffmann D; Park A; Chowdhury PS; Rao SP
MAbs; 2021; 13(1):1904546. PubMed ID: 33899674
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
